Access Reminder for Bruker Investor Webinar on May 17, 2024
Bruker (Nasdaq: BRKR) will host an Investor Webinar on May 17, 2024, from 10 am to 12 noon EDT. The webinar will cover Bruker’s three recent acquisitions: Chemspeed, ELITech, and the NanoString business. Presentations will be given by CEO Frank H. Laukien, CFO Gerald Herman, and leaders of the new acquisitions. A medium-term financial outlook update will also be provided. The event will include a live Q&A session for analysts and investors. Webinar access details will be available on Bruker’s Investor Relations website, with a replay available post-event.
- Bruker is hosting an Investor Webinar, showing transparency and engagement with shareholders.
- The webinar will provide insights into three recent acquisitions: Chemspeed, ELITech, and NanoString, demonstrating growth and expansion.
- An update to the medium-term financial outlook will be provided, which shows forward planning and potential growth.
- Presentations by key executives, including CEO Frank H. Laukien and CFO Gerald Herman, ensure authoritative insights.
- A live Q&A session allows for direct interaction with analysts and investors, enhancing trust and clarity.
- The PR does not provide specific financial data or performance metrics for the recent acquisitions, leaving investors in the dark about immediate impacts.
- No concrete details on the medium-term financial outlook were offered in the PR, making it unclear if the outlook is positive or negative.
- There may be risks associated with integrating three different businesses, which are not addressed in the PR.
The Investor Webinar will include presentations by CEO Frank H. Laukien, CFO Gerald Herman, and by the leaders of these three new Bruker businesses, Bernd Gleixner, Christoph Gauer and Mark Munch. The presentations will followed by a live Q&A session for analysts and investors.
The link to the Investor Webinar and dial-in option info will be available in the Events & Presentations section of the Company’s Investor Relations website at https://ir.bruker.com. A replay will be available on Bruker’s Investor Relations website after the conclusion of the event.
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240516258602/en/
Justin Ward
Sr. Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com
Source: Bruker Corporation
FAQ
When is Bruker's Investor Webinar?
What will Bruker discuss in the Investor Webinar?
Who will present at Bruker's Investor Webinar?
Will there be a Q&A session at Bruker's Investor Webinar?
Where can I access Bruker's Investor Webinar?
